Reston, Va. SNM's Molecular Imaging Center of Excellence (MICoE) is changing its name effective Oct. 1, 2010, to the Center for Molecular Imaging Innovation and Translation (CMIIT), a designation that reflects its new mission and vision.
"The MICoE was created five years ago to help integrate all aspects of molecular imaging into the structure and mission of SNM," said Carolyn J. Anderson, Ph.D., president of MICoE, now CMIIT, and a professor of radiology, biochemistry & molecular biophysics and chemistry at Washington University in St. Louis. "Since that time, SNM has evolved into a society that welcomes and integrates all molecular imaging modalities. This led the center to narrow its focusreflected in its new vision, mission and nameto the innovation and translation of molecular imaging techniques."
CMIIT's mission is to engage the molecular imaging community and leverage the SNM infrastructure to advance the adoption of emerging molecular imaging technologies and probes in preclinical and clinical applications. The guiding vision for CMIIT is for molecular imaging to become an integral part of the medical standard of care by providing specific information that will be used for diagnosis and to guide therapeutic decisions that improve health and well-being.
By collaborating with academic centers, industry, and philanthropic and government agencies, CMIIT will help establish a pathway for integrating emerging molecular imaging technologies into basic science, drug discovery, clinical trials and routine practice.
"CMIIT will place a major focus on translational researchmoving basic science in molecular imaging into clinical practice," said Dominique Delbeke, M.D., Ph.D., president of SNM and the director of nuclear medicine and positron emission tomography in the Department of Radiology and Radiological Sciences at Vanderbilt University, Nashville, Tenn. "These continuing efforts will make SNM and CMIIT an effective advoc
|Contact: Jane Kollmer|
Society of Nuclear Medicine